Basic information Safety Supplier Related

GS 389

Basic information Safety Supplier Related

GS 389 Basic information

Product Name:
GS 389
Synonyms:
  • GS 389
  • 1,2,3,4-Tetrahydro-1-(4-methoxybenzyl)-6,7-dimethoxyisoquinoline
  • 1,2,3,4-Tetrahydro-6,7-dimethoxy-1-(4-methoxybenzyl)isoquinoline
  • 6,7-diMethoxy-1-(4-Methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-2-iuM chloride
  • 6,7-Dimethoxy-1-(4-methoxybenzyl)-1,2,3,4-tetrahydroisoquinoline
  • HIGE-004
  • Isoquinoline, 1,2,3,4-tetrahydro-6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-
CAS:
41498-37-7
MF:
C19H23NO3
MW:
313.39
EINECS:
1533716-785-6
Mol File:
41498-37-7.mol
More
Less

GS 389 Chemical Properties

Melting point:
200-203 °C
Boiling point:
454.0±45.0 °C(Predicted)
Density 
1.108±0.06 g/cm3(Predicted)
pka
8.75±0.40(Predicted)
More
Less

GS 389 Usage And Synthesis

Description

GS 389 is a novel tetrahydroisoquinoline analog. GS-389 significantly increased cGMP levels in the rat aorta and inhibited cGMP phosphodiesterase from the rabbit brain. It has vasorelaxant properties.

Uses

GS 389 ((±)-O,O-Dimethylcoclaurine) is a tetrahydroisoquinoline. GS-389 inhibites Cyclic AMP and cyclic AMP dependent phosphodiesterases from rat atrial and ventricular tissue. GS-389 relaxes the contraction induced by phenylephrine and high K+ in rat aortic rings[1].

References

[1] Chang KC, et al. Different pharmacological characteristics of structurally similar benzylisoquinoline analogs, papaverine, higenamine, and GS 389, on isolated rat aorta and heart. Can J Physiol Pharmacol. 1994;72(4):327-334. DOI:10.1139/y94-049

GS 389Supplier

BePharm Ltd
Tel
400-685-9117
Email
market@bepharm.com
Hubei Xinyuanshun Pharmaceutical Chemical Co., Ltd.
Tel
027-51831887 15337167856
Email
hubeixinyuanshun@163.com
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Hubei Xinyang Medical Technology Co., Ltd
Tel
15347293736
Email
2853117764@qq.com
Chemsigma International Co., Ltd.
Tel
025-58748998 18951874644
Email
elsa.cheng@chemsigma.com